Li Sumeng, Liu Jing, Wu Jun, Zheng Xin
Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan 430022, China.
Cells. 2025 May 15;14(10):718. doi: 10.3390/cells14100718.
Acute-on-chronic liver failure (ACLF) is a severe clinical syndrome characterized by high morbidity and mortality rates. Bacterial infection is a frequent precipitating factor and complication in ACLF patients, significantly worsening patient outcomes. Elucidating the mechanisms underlying bacterial infections and their impact on ACLF pathophysiology is crucial for developing effective therapies to reduce infection rates and mortality. Current research highlights that immune suppression in ACLF increases susceptibility to bacterial infections, which in turn exacerbate immune dysfunction. However, a comprehensive review summarizing the emerging mechanisms underlying this immunosuppression is currently lacking. This review aims to provide an overview of the latest research, focusing on alterations in the immune responses of innate immune cells-including monocytes, macrophages, and neutrophils-as well as adaptive immune cells such as T and B lymphocytes during the onset and progression of bacterial infections in ACLF. In addition, recent advances in immunomodulatory therapies, including stem cell-based interventions, will also be discussed.
慢加急性肝衰竭(ACLF)是一种严重的临床综合征,其发病率和死亡率都很高。细菌感染是ACLF患者常见的诱发因素和并发症,会显著恶化患者的预后。阐明细菌感染的潜在机制及其对ACLF病理生理学的影响,对于开发有效的治疗方法以降低感染率和死亡率至关重要。目前的研究表明,ACLF中的免疫抑制会增加对细菌感染的易感性,进而加剧免疫功能障碍。然而,目前缺乏对这种免疫抑制潜在新机制的全面综述。本综述旨在概述最新研究,重点关注在ACLF患者细菌感染发生和进展过程中,先天免疫细胞(包括单核细胞、巨噬细胞和中性粒细胞)以及适应性免疫细胞(如T淋巴细胞和B淋巴细胞)免疫反应的变化。此外,还将讨论免疫调节治疗的最新进展,包括基于干细胞的干预措施。